FADHL AL-SHAEBI

Dr. FADHL AL-SHAEBI

Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, China
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2022 in Cellular & Molecular Biology Letters
Verified
Journal Article
Open access
PDF file
MAMahmoud Al-Azab
Mahmoud Al-Azab
MSMohammed Safi
Mohammed Safi
EIElina Idiiatullina
Elina Idiiatullina
FADHL AL-SHAEBIFADHL AL-SHAEBI
FADHL AL-SHAEBI
MZMohamed Y. Zaky
Mohamed Y. Zaky
Human mesenchymal stem cells (MSCs) are primary multipotent cells capable of differentiating into osteocytes, chondrocytes, and adipocytes when stimulated under appropriate conditions. The role of MSCs in tissue homeostasis, aging-related diseases, and cellular therapy is clinically suggested. As aging is a universal problem that has large socioeconomic effects, an improved understanding of the concepts of aging can direct public policies that reduce its adverse impacts on the healthcare system and humanity. Several studies of aging have been carried out over several years to understand the phenomenon and different factors affecting human aging. A reduced ability of adult stem cell populations to reproduce and regenerate is one of the main contributors to the human aging process. In this context, MSCs senescence is a major challenge in front of cellular therapy advancement. Many factors, ranging from genetic and metabolic pathways to extrinsic factors through various cellular signaling pathways, are involved in regulating the mechanism of MSC senescence. To better understand and reverse cellular senescence, this review highlights the underlying mechanisms and signs of MSC cellular senescence, and discusses the strategies to combat aging and cellular senescence. Graphical Abstract

1 November 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MAMaged Almezgagi
Maged Almezgagi
YZYu Zhang
Yu Zhang
KHKamal Hezam
Kamal Hezam
ESEmad Shamsan
Emad Shamsan
MGMohammed Gamah
Mohammed Gamah
WZWei Zhang
Wei Zhang
Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) and the active metabolite is rhein. It is a non-steroidal anti-inflammatory drug with unique pharmacological properties as anti-oxidant and anti-apoptosis. Diacerein has recently shown to have a potential role by mediating anti-inflammatory as well as anti-oxidant and anti-apoptosis in kidney injury, diabetes mullites, and a beneficial effect on pain relief. It may have a therapeutic role in cancer, ulcerative colitis, testicular injury and cervical hyperkeratosis. Furthermore, diacerein has a valuable addition in combination therapy as a synergetic agent. This review, the first of its kind, highlights the proposed roles of diacerein in osteoarthritis and discusses recent results supporting its emerging roles with a particular focus on how these new insights may facilitate the rational development of diacerein for targeted therapies in the future.

21 July 2021 in Brain and Behavior
Verified
Journal Article
Open access
Arshad MehmoodArshad Mehmood
Arshad Mehmood
WAWajid Ali
Wajid Ali
ZDZaheer Ud Din
Zaheer Ud Din
SSShuang Song
Shuang Song
MSMuhammad Sohail
Muhammad Sohail
BLBin Li
Bin Li
Recently, genome‐editing technology like clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 has improved the translational gap in the treatments mediated through gene therapy. The advantages of the CRISPR system, such as, work in the living cells and tissues, candidate this technique for the employing in experiments and the therapy of central nervous system diseases. Parkinson's disease (PD) is a widespread, disabling, neurodegenerative disease induced by dopaminergic neuron loss and linked to progressive motor impairment. Pathophysiological basis knowledge of PD has modified the PD classification model and expresses in the sporadic and familial types. Analyses of the earliest genetic linkage have shown in PD the inclusion of synuclein alpha (SNCA) genomic duplication and SNCA mutations in the familial types of PD pathogenesis. This review analyzes the structure, development, and function in genome editing regulated through the CRISPR/Cas9. Also, it explains the genes associated with PD pathogenesis and the appropriate modifications to favor PD. This study follows the direction by understanding the PD linking analyses in which the CRISPR technique is applied. Finally, this study explains the limitations and future trends of CRISPR service in relation to the genome‐editing process in PD patients' induced pluripotent stem cells.

1 December 2020 in International Immunopharmacology
Verified
Journal Article
Closed access
FADHL AL-SHAEBIFADHL AL-SHAEBI
FADHL AL-SHAEBI
LWLiang Wenzhang
Liang Wenzhang
KHKamal Hezam
Kamal Hezam
MAMaged Almezgagi
Maged Almezgagi
LWLin Wei
Lin Wei

12 July 2021 in Journal of Virology
Verified
Journal Article
Open access
WLWenzhang Liang
Wenzhang Liang
YZYue Zhang
Yue Zhang
MLMiao Li
Miao Li
FADHL AL-SHAEBIFADHL AL-SHAEBI
FADHL AL-SHAEBI
JLJian Li
Jian Li
LWLin Wei
Lin Wei
RSV-N, packed in the viral genome to form the ribonucleoprotein (RNP) complex, which is recognized by the RSV RNA-dependent RNA polymerase (RdRp) complex to initiate viral replication and transcription, plays an indispensable role in the viral biosynthesis process. cypA, binding to RSV-N, may impair this function by weakening the interaction between RSV-N and RSV-P, thus leading to decreased viral production. Our research provides novel insight into cypA antiviral function, including binding to viral capsid protein to inhibit viral replication, which may be helpful for new antiviral drug exploration.

1 January 2021 in Clinical Laboratory
Verified
Journal Article
Closed access
reem Alariqireem Alariqi
reem Alariqi
ZZZhao-Hua Zhong
Zhao-Hua Zhong
WAWadee Al-Shehari
Wadee Al-Shehari
FADHL AL-SHAEBIFADHL AL-SHAEBI
FADHL AL-SHAEBI
GAGehad Amran
Gehad Amran
AAAhmad Askary
Ahmad Askary
Pseudomonas aeruginosa is a Gram-negative bacteria that causes a large range of human infections such as lung infection (cystic fibrosis) and urinary tract infection. Even worse, antibiotic resistant bacteria have become a serious health care problem throughout the last decade, and there is a need for a clear approach to regulate and prevent the spread of pseudomonas aeruginosa resistance. A complete analysis of Pseudomonas aeruginosa proteomics data showed that 25% of proteins are hypothetical proteins (HPs) whose function is not precisely defined. HP gene sequence analysis offers a framework for defining sequence-function relationships with a deeper understanding of organisms' molecular mechanisms at the system level. In the current research, we used the power of different bioinformatics tools to assign the potential roles for the HPs based on protein family association, amino acid function, motifs, and pathway analysis. The current findings show that 30 HPs have well-defined functions and are classified as enzymes, DNA binding, periplasmic binding protein, transport, etc. Seven HPs showed virulence characteristics that is to be expected to be essential for Pseudomonas aeruginosa and pathogenesis survival. This study's findings may encourage a better understanding of virulence mechanisms, drug resistance, pathogenesis, and drug discovery to treat Pseudomonas aeruginosa infections.
1